Document is current
Any future updates will be listed below
-
Authors
Cui, Chuanliang
Xu, Canqiang
Yang, Wenxian https://orcid.org/0000-0002-5349-9680
Chi, Zhihong
Sheng, Xinan https://orcid.org/0000-0001-9359-0975
Si, Lu
Xie, Yihong
Yu, Jinyu
Wang, Shun
Yu, Rongshan https://orcid.org/0000-0003-2179-173X
Guo, Jun https://orcid.org/0000-0003-1759-0986
Kong, Yan https://orcid.org/0000-0002-2266-7872
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81772912)
National Natural Science Foundation of China (81672696)
National Natural Science Foundation of China (81972557)
Natural Science Foundation of Beijing Municipality (7202022)
- License Information
-
More Information
Article History
Received: 9 June 2020
Accepted: 6 January 2021
First Online: 4 February 2021
Competing interests
: J.G., the corresponding author, has the following consulting or advisory roles: MSD, Roche, Pfizer, Bayer, Novartis, Simcere Pharmaceutical Group, Shanghai Junshi Biosciences, Oriengene. The remaining authors declare no competing interests.
